These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10095083)

  • 1. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway.
    Hanson GR; Keefe KA
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):111-21. PubMed ID: 10095083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
    Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats.
    Haberny SL; Carr KD
    Brain Res Mol Brain Res; 2005 Nov; 141(2):121-7. PubMed ID: 16257473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.
    Midgley LP; Wagstaff JD; Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1994 Jan; 251(2-3):191-9. PubMed ID: 7908639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.
    Yamamoto N; Soghomonian JJ
    Neuroscience; 2008 Jun; 154(3):1088-99. PubMed ID: 18495353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the acoustic startle response by dopamine agonists after 6-hydroxydopamine lesions of the substantia nigra pars compacta: corresponding changes in c-Fos expression in the caudate-putamen.
    Meloni EG; Davis M
    Brain Res; 2000 Oct; 879(1-2):93-104. PubMed ID: 11011010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in CArG-binding protein A expression levels following injection(s) of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat.
    Rushlow WJ; Rajakumar B; Flumerfelt BA; Naus CC; Rajakumar N
    Neuroscience; 2000; 98(1):69-78. PubMed ID: 10858613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
    Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
    Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function.
    Fawaz CS; Martel P; Leo D; Trudeau LE
    BMC Neurosci; 2009 Aug; 10():96. PubMed ID: 19682375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.
    Alburges ME; Hoonakker AJ; Hanson GR
    Eur J Pharmacol; 2007 Nov; 573(1-3):124-32. PubMed ID: 17689525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.